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We tested the hypothesis that in utero exposure to heavy metals increases autism-like behavioral phenotypes in adult animals and
induces epigenetic changes in genes that have roles in the etiology of autism.Mouse damswere treatedwith cadmium, lead, arsenate,
manganese, and mercury via drinking water from gestational days (E) 1–10. Valproic acid (VPA) injected intraperitoneally once on
(E) 8.5 served as a positive control. Young male offspring were tested for behavioral deficits using four standardized behavioral
assays. In this study, in utero exposure to heavy metals resulted in multiple behavioral abnormalities that persisted into adulthood.
VPA and manganese induced changes in perseverative/impulsive behavior and social dominance behavior, arsenic caused changes
only in perseverative/impulsive behavior, and lead induced abnormalities in social interaction in comparison to the control animals.
Brain samples fromMn, Pb, andVPA treated and control animalswere evaluated for changes inCpG islandmethylation in promoter
regions and associated changes in gene expression. The Chd7 gene, essential for neural crest cell migration and patterning, was
found to be hypomethylated in each experimental animal tested compared to water-treated controls. Furthermore, distinct patterns
of CpG island methylation yielded novel candidate genes for further investigation.
1. Introduction
Autism spectrum disorder (ASD), commonly referred to
as autism, is diagnosed in 1 of every 68 children in the
United States and is characterized by a range of com-
plex neurodevelopment disorders. Diagnostic and Statistical
Manual of Mental Disorders (DSM-5) define ASD as a
neurobehavioral disorder manifested by persistent deficits in
social and communication interaction, deficits in developing,
understanding, andmaintaining relationships, and abnormal
and fixed interests and repetitive behavior [1]. Accumulating
evidence suggests that epigenetic factors play a strong role in
the etiology ofASD [2–6]. Epigenetic disruption of regulatory
CpG islands has also been associated with autism. For exam-
ple, a decrease in expression of the methyl binding protein
gene, MECP2, was observed in the brain tissue of autistic
patients. Downregulation of MeCP2 was also demonstrated
in valproate animal model of autism [7]. This gene functions
as a transcriptional repressor at specific gene promoters
crucial to brain development [8, 9].
Valproic acid (VPA) is a commonly used antiepileptic
drug. In utero exposure to VPA increases the risk for neural
tube defects (NTDs) in humans [10, 11] and laboratory
rodents [12]. VPA is also known to cause behaviors con-
sistent with some aspects of autism and is employed as
an established research model for inducing autism [13, 14].
Years of preliminary data suggest that there is a genetic basis
underlying VPA-sensitivity to the induction of neural deficits
in laboratory animals [15–17]. VPA is also known to affect the
epigenome, as well as blood levels of folate and homocysteine,
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both of which have the potential to dysregulate critical
developmental genes that can result in adverse pregnancy
outcomes [18, 19]. A growing body of literature indicates
that similar disruption is observed in some autistic patients:
both disrupted folate and homocysteine status [20–22] and
epigenomic disruption of regulatory CpG islands have been
associated with autism [23]. Furthermore, evidence suggests
that exposure to environmental neurotoxins is a risk factor
for autism [24].
Industrial chemicals are being produced and released into
the environment at a staggering rate. The average consumer
is exposed to up to 10,000 different chemicals every day
out of a world market that includes over 30,000 industrial
chemicals sold at quantities greater than 400 million tons
per year [25]. These chemicals range in toxicity from being
benign to being extremely hazardous and the environmental
and public health implications of this overwhelming and
pervasive exposure have not been well characterized for the
vast majority of chemicals. Among the hazardous toxicants,
heavy metals, known neurotoxicants continue to be of a
great concern due to their increasing anthropogenic presence
in the environment [26]. Several epidemiological studies
reported a relationship between autism and heavy metal
biomarkers [27, 28]. Exposure to industrial chemicals has
been thought to play a role in the etiology of autism through
epigenetic mechanisms.This is based on evidence suggesting
the plausibility of a role for mercury in the etiology of autism
[29, 30], and mercury in maternal peripheral and cord blood
has been shown to affect fetal epigenetic status [31]. A handful
of reports also points out to other heavy metals neurotoxicity
and epigenetic mechanism [32, 33].
The experiments presented in this paper were designed
to identify abnormal neurobehavioral phenotypes resulting
from in utero exposure to several identified environmental
pollutants. We hypothesized that in utero exposure to these
toxicants results in epigenetic changes in key developmental
genes, affecting pathways that have direct roles in the etiology
of autism. Collectively, this work provides an assessment of
the effect of in utero exposure to selected heavy metals on
the epigenome and associated autistic-like phenotypes in the
offspring that persist as adult behaviors.
2. Materials and Methods
2.1. General Study Design. C57BL/6J mice were exposed in
utero to selected toxicants and evaluated for their adult
behavioral phenotype. VPA was used as a positive control
because it is a widely used mitochondriotoxic medication
that induces a spectrum of teratogenic effects including
behavioral disruption and is used as a rodent model for
studying autistic behavioral changes [34]. Environmental
toxicants including cadmium (Cd), lead (Pb), arsenic (As),
manganese (Mn), and mercury (Hg) were investigated with
normal drinking water used as a negative control.
2.2. Animals and Housing. C57B6/J mice were housed in
the Institute of Biosciences and Technology Vivarium, which
is fully accredited by the Association for Assessment and
Accreditation of Laboratory Animal Care. The animals were
maintained in clear polycarbonate microisolator cages and
were allowed free access to food and water (Harlan Teklad
Rodent Diet #8606, Ralston Purina, St. Louis, MO). The
mice were maintained on a 12 h light/dark cycle. Nulligravid
females, 50–70 days of age, were mated overnight with males
and examined for the presence of vaginal plugs the following
morning and the onset of gestation was considered to be
10 p.m. of the previous night, the midpoint of the dark cycle.
2.3. Treatment with Select Compounds. Presumed gravid
dams C57BL/6J were treated with one of seven agents: drink-
ingwater served as the negative control andVPA (CAS# 1069-
66-5, valproic acid sodium salt, ≥98%, Sigma-Aldrich Chem-
icals, St. Louis, MO) administered at 600mg/kg by intraperi-
toneal injection on gestational day 8.5 only served as the
positive control. Five groups were treated from the first day
of pregnancy through day 10.5, the end of neurulation, which
generally occurs from E8.0–10.5, via treated drinking water
containing 10 ppmCd as cadmium chloride (CAS# 10108-64-
2, 99.99% trace metals basis, Sigma-Aldrich Chemicals, St.
Louis, MO), 300 ppm Pb as lead acetate (CAS# 6080-56-4,
lead(II) acetate trihydrate, 99.999% tracemetals basis, Sigma-
Aldrich Chemicals, St. Louis, MO), 0.5 ppm As as sodium
arsenate (CAS# 10048-95-0, sodium arsenate heptahydrate,
ACS Reagent, ≥98%, Sigma-Aldrich Chemicals, St. Louis,
MO), 10 ppm Mn as manganese chloride (CAS# 13446-34-
9, manganese(II) chloride tetrahydrate, 99.99% trace metals
basis, Sigma-Aldrich Chemicals, St. Louis, MO), or 20 ppm
Hg as mercury chloride (CAS# 7487-94-7, mercury(II) chlo-
ride, ACS reagent, ≥99.9%, Sigma-Aldrich Chemicals, St.
Louis, MO). Treated dams maintained in separate cages were
allowed to give birth. Only animals from litters consisting of
6–8 pups were admitted for further testing. All experimental
mice were weaned at three weeks of age and maintained in
separate cages. Because of the higher incidence of autism
reported in male children as compared to female children,
malemice were used exclusively in these studies. Twelvemice
per group that is seventy two males in total were used in
this study. Animals were assigned randomly to experimental
groups and to reduce any litter effect only one male from a
given litter was assigned to the same treatment group (no
littermates in the same group).
2.4. Behavioral Assays and Statistical Analysis. Thebehavioral
testing began when experimental animals reached twelve
weeks of age and lasted until twenty weeks of age with at
least one-week break period between consecutive assays for
any individual mouse. All treatment groups were evaluated
with 4 different neurobehavioral assays: nest building to
begin to assess behavioral deficits; marble burying for per-
severative/impulsive behaviors; 3-chambered box for social
interaction; and tube test for social dominance. Each assay
was performed sequentially, such that the least stressful assay
was performed first and the most stressful performed last:
nest building, marble burying, 3-chambered box for social
interaction, and tube test.
2.4.1. Nest Building. Upon reaching twelve weeks of age,
mice were tested for their ability to build nests. C57 mice
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are considered exceptionally robust nest builders, a normal
behavior for both male and female mice. Nesting has been
reported to be impaired by brain lesions including those
to the hippocampus and medial prefrontal cortex [35],
pharmaceutical intervention with selective serotonin reup-
take inhibitors (SSRIs) [36], and disease (e.g., scrapie) [37].
Nestlets (Ancare, Bellmore, NY), manufactured from pulped
virgin cotton fiber and sterilized during the manufacturing
process, were routinely provided in each cage. Three grams
of Nestlet was placed in each cleaned cage 1 hour prior to
the onset of the dark cycle and left undisturbed overnight.
Nest building was assessed based on a 5-point scale, 1: Nestlet
not noticeably touched; 2: Nestlet partially torn; 3: Nestlet
mostly shredded, but no identifiable nest; 4: identifiable, but
flat nest; and 5: a near perfect nest. Data were analyzed using
a nonparametric ANOVA (Kruskal-Wallis test) with Dunn’s
multiple comparison test.
2.4.2. Marble Burying. Mice were tested for persevera-
tive/impulsive behavior using marble burying as an index.
As mice dig, a normal behavior, marbles are incidentally
submerged in litter. It is suggested that this is a genetically
regulated behavior which is not related to anxiety or novelty
[38, 39]. This repetitive/perseverative behavior has been
observed to be disrupted by awide array of agents that include
hippocampal lesions [40], NK1 antagonists [41], and many
more [42–44]. Mice were presented with 16 marbles in a 4 ×
4 grid placed lightly on a gently tamped volume of aspen chip
bedding 5 cm deep and allowed 30 minutes to bury marbles.
Marbles were considered buried if >70% of the marble
volume was submerged. The numbers of marbles buried
were recorded and analyzed using a nonparametric ANOVA
(Kruskal-Wallis test) with Dunn’s multiple comparison
test.
2.4.3. Three-Chambered Social Testing Apparatus. In this
assay we tested the normal preference of a mouse to
investigate and spend time with a novel strange mouse, as
opposed to a novel object.The three-chambered social testing
apparatus was designed at NIH in order to measure various
aspects of sociability in mice [45]. Three chambers are linked
by closeable gates; transitions between chambers and time
spent in each chamber may be recorded by a computerized
monitoring program.
The test mouse was placed in the closed central chamber
(#2) of the apparatus and allowed to acclimate for ten
minutes. Next, a novel strange mouse was placed under an
inverted wire cup in chambers #1 or #3, with a duplicate
cup placed in the remaining chamber, the gates between the
chambers were raised, and the behavior of the mouse was
recorded for ten minutes. Total time spent with the novel
strange mouse versus the novel object was analyzed with a
2-tailed paired 𝑡-test for each treatment group. Failure to
achieve a statistically significant preference for spending time
with a novel stranger was considered indicative of abnormal
behavior. A set of novel stranger mice had been previously
acclimated to being restrained for 10-minute periods within
the confines of the inverted cup. The stranger mice were
alternated from side one to side three to ensure that a
preference for a specific side by the test mice did not
confound the outcome. Similarly, the apparatus was housed
in a room with an ambient noise level of 55 db, provided
by the ventilation fan and placed directly under a light. The
apparatus was wiped down with 70% ethanol at the onset of
investigations and between mice thereafter.
2.4.4. Tube Test for Social Dominance. Mice were tested for
a preference, when challenged with a novel strange mouse at
opposing ends of a 12󸀠󸀠 long PVC pipe, to yield to the novel
stranger and back out of the tube (lose) or complete transit of
the tube while the novel stranger yields (win). Disruption of
normal behavior has been reported in mice that recapitulate
many characteristic features of autism-like behavior, such as
thosewith a truncatedMeCP2 that recapitulatemany features
of Rett Syndrome [46] and chromosome deletions causing
classic features of Williams-Beuren syndrome, such as
hypersociability [47]. Each test mouse was challenged three
times with a novel strange mouse for a maximum allotted
time of four minutes (a match). Mice were placed headfirst
at opposite ends of a tube and released simultaneously. The
match ended when one retreated from the tube and was
assigned a score of zero (lose); the remaining mouse was
assigned a score of one (win). Stranger mice were generally
used three times and nomore than four times. Both test mice
and stranger mice were separately acclimated to the testing
apparatus in advance of testing. Failure to achieve a win/loss
outcome in four minutes, or the mice crossing over each
other to exit opposite ends of the tube, excluded the match
from scoring. The outcome from the three matches for each
mouse was calculated as an average percentage of wins and
then the mean percentage of win matches was calculated
for each treatment group. These mean values were analyzed
using a nonparametric ANOVA (Kruskal-Wallis test) with
Dunn’s multiple comparison test.
2.5. TissueHarvest andMolecular Assays. Three animals from
negative control group and from each of the groups that
exhibited changes in the greatest number of behavioral assays
(water control, VPA, Mn, and Pb) were evaluated for changes
in frontal cortex CpG islandmethylation in promoter regions
and associated changes in gene expression that similarly
persisted into adulthood.
After all behavioral assays were complete, experimental
mice were euthanized via CO
2
asphyxiation and brain tissue
immediately harvested. The frontal cortex was dissected
out and divided for extraction of DNA and RNA used in
subsequent molecular assays. Agilent’s Mouse CpG Island
Microarray and Genomic DNA Enzymatic Labeling Kit
(Agilent, Santa Clara, CA) were used to identify changes
in methylation of genes previously known to be important
for early neurodevelopment, as well as identifying novel
candidate genes. The 2 × 105K format interrogates over
16,000 CpG islands using 97,652 probes in or within 95 bp of
CpG islands and was sourced from UCSCmm8 (NCBI Build
36).
Briefly, genomic DNA was isolated and subsequent per-
formance of the array was performed by MOgene (St. Louis,
MO). Whole genomic DNA was sheared (reference DNA)
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and labeled with Cy5 (blue). Methylated DNA was precipi-
tated from each sample and labeled with Cy3 (red). The sam-
ples were then hybridized to the slide for 40 hours followed
by washing, drying, and imaging. Data were extracted using
the Feature Extraction software and methylation protocol.
In order to view and search for high-level patterns in the
results for each experimental analysis, hierarchical clustering
was performed. Data tables were prepared as tab-delimited
text files and loaded intoHierarchical Clustering Explorer 3.0
(University of Maryland, College Park, MD).
Upon completion of data analysis, microarray results
were validated by real-time quantitative PCR using TaqMan
Gene Expression Assays on an ABI 3730 DNA 7900HT
Genetic Analyzer (Life Technologies, Carlsbad, CA) for those
genes identified as having altered histone methylation. Gene-
specific probes and primer sets were purchased from Life
Technologies. 50 ng cDNA of each sample was mixed with
10 𝜇L TaqMan Gene Expression PCR Master Mix and 1 𝜇L
probe and primer mixture in a total volume of 20 𝜇L in a
384-well plate. The assays were performed according to the
manufacturer’s protocol on anABI PRISM7900HT Sequence
Detection System. The thermocycling started with a 10min
denaturing at 95∘C, followed by 40 cycles of 95∘C for 15 sec
and 60∘C for 1min. Data was analyzed using SDS software
v2.1. Mouse Actb gene was used as internal control. ΔΔCt
methodwas used to generate relative quantitative values (fold
change). Each reactionwas replicated two times and themean
value was used in final comparisons.
3. Results
3.1. Behavioral Assays
3.1.1. Nest Building Assay. All mice in this study made nests
that scored a 5 on a whole integer scale of 1–5. No statistically
significant differences between the nests of water-treated
control mice and those of mice exposed to toxicants in utero
were observed.
3.1.2. Marble-Burying Test. C57 mice were vigorous diggers,
with water-treated controls burying nearly 70% of the mar-
bles placed on the surface of the lightly packed bedding.
Animals from all treated groups buried fewer marbles but
statistically significant difference was confirmed only in
three groups. VPA, As, and Mn exposed animals buried
significantly fewer marbles than water-treated control mice
with the 𝑝 values less than 0.05, 0.01, and 0.01, respectively
(Figures 1 and 2).
3.1.3. Three-Chambered Testing Apparatus for Social Interac-
tion. Exposure to one toxicant, Pb, resulted in an abnormal
lack of preference for spending time with a novel stranger
mouse. Statistical analysis revealed that mice treated with Pb
did not spend significantly more time with novel stranger
mouse than with the novel object (𝑝 = 0.396). Water-treated
control mice, as well as all other treatment groups, with the
exception of Pb, displayed a normal preference for spending
time with a novel stranger mouse rather than with a novel
Table 1: Tube test for social dominance.
Treatment % wins 𝑝 value
Ctl (𝑛 = 36) 49.5
VPA (𝑛 = 36) 22.0 <0.05
Cd (𝑛 = 36) 30.3 >0.05
Pb (𝑛 = 36) 44.3a >0.05
As (𝑛 = 36) 52.5 >0.05
Mn (𝑛 = 36) 19.2 <0.01
Hg (𝑛 = 36) 28.9 >0.05
The mean values were analyzed using a nonparametric ANOVA (Kruskal-
Wallis test) with Dunn’s multiple comparison test.
a25% of matches crossed over or “timed out,” leaving the match unscored.
object. The observed differences (time with strange mouse −
time with a novel object) were statistically significant with a
𝑝 values ranging from 0.003 to 0.0001 (Figure 3).
3.1.4. Tube Test for Social Dominance. Mice from water-
treated control group on average won half (49.5%) of their
matches. On the other hand, the VPA-exposed mice experi-
enced significantly more losses (only 22% wins) as compared
to water-treated controls (𝑝 < 0.05). The Mn-exposed mice
experienced evenmore losses (only 19.2%wins𝑝 < 0.01).The
tube test identified also abnormal behavior of th Pb-exposed
mice. Even though the Pb-exposed group won 44.3% of their
matches (not significantly different form control group 𝑝 >
0.05), these matches were very long and 25% of the matches
were unscored when the animals crossed over one another to
exit the tube or simply remained in the tube together for the
full 4 minutes of the match period. This behaviour was not
observed in any other tested group (Table 1).
3.1.5. Overview of Behavioral Studies. While none of the
treatment groups displayed abnormal behavior in all four
assays, 3 treatment groups displayed abnormal behavior in 2
of the assays when compared to water-treated controls: VPA
(marble burying and tube test),Mn (marble burying and tube
test), and Pb (three-chambered testing apparatus for social
interaction and tube test). Molecular assays were performed
using tissue from the frontal cortex of representative animals:
three animals from each of the most affected groups (VPA,
Mn, and Pb) and water control were used (Table 2).
3.2. Molecular Assays
3.2.1.MouseCpG IslandMicroarray forAlteredHistoneMethy-
lation. CpG array probe names were associated with gene
IDs (UCSC Genome Browser) and analyzed for significant
differences using Student’s 𝑡-test (𝑝 < 0.05) and a twofold
change in average probe signal for treated versus control
groups (Table 3). Clustering on the untransformed data using
Average Linkage (UPGMA) with similarity represented by
EuclideanDistance indicated that clusters fit expected groups
based on treatment type (Figure 4). Further, one region was
found with lower regulation in all treatment groups. This
region is 5󸀠 of the chromodomain-helicase-DNA-binding
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(a) (b)
(c)
Figure 1: Marble-burying apparatus. (a) Marble-burying apparatus ready for use. (b) Marble-burying apparatus after use by representative
VPA-treated animal. (c) Marble-burying apparatus after use by representative normal control animal.
0
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10
12
14
Control VPA Cd Pb As Mn Hg
Mean number of buried marbles
∗
∗∗ ∗∗
Figure 2:Marble-burying test for perseverative/repetitive behavior:
VPA, As, and Mn exposed animals bury significantly fewer marbles
than controls. Data were analyzed using the nonparametric ANOVA
(Kruskal-Wallis test) with Dunn’s multiple comparison test. ∗
denotes statistical significance (𝑝 < 0.05); ∗∗ denotes statistical
significance (𝑝 < 0.001).
protein 7 (Chd7) gene, which was found to be hypomethy-
lated in each sample tested from the three experimental
groups displaying the most altered behavior (Table 3).
3.2.2. Enrichment Analysis. A web-based analysis toolkit
(WEB-based Gene SeT AnaLysis Toolkit, WebGestalt) [48]
was utilized for enrichment analysis of genes adjacent to
CpG enriched regions from the CpGmicroarray. Specifically,
M. musculus was queried using gene symbols. Enrichment
0
50
100
150
200
250
300
350
Control VPA Cd Pb As Mn Hg
(s
)
Mean time spent in a chamber
With novel mouse
With novel object
∗ ∗
∗ ∗∗∗
Figure 3:Three-chambered testing apparatus for social interaction:
mice from all groups except the Pb exposed group exhibited a
normal preference to spend significantly more time with a novel
stranger mouse rather than with a novel object. Data were analyzed
with a 2-tailed paired 𝑡-test for each treatment group.The preference
was statistically significant in all groups (0.002 < 𝑝 < 0.04 range),
but Pb treated group (𝑝 > 0.05). ∗ denotes statistical significance.
analysis utilized genome query, hypergeometric method,
with significance set at 𝑝 < 0.05 with Bonferroni cor-
rection. Gene enrichment is reported for Gene Ontol-
ogy. For VPA, anatomical structure formation involved in
morphogenesis (GO:0048646) was the most significantly
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Figure 4: Mouse CpG Island Microarray for altered histone methylation. Hierarchical clustering of the untransformed data was done using
Average Linkage (UPGMA) with similarity represented by Euclidean Distance. Data filtering: the genomic results were filtered from the
UCSC (http://genome.ucsc.edu/) Mouse Genome Browser Gateway (NCBI37/mm9) for being within a CpG island and 5󸀠 of a known gene.
The samples clustered according to the treatment type.
Table 2: Metatable for behavioral studies.
Treatment Marble burying 3-chambered box Tube test
VPA (𝑛 = 12) X X
Cd (𝑛 = 12)
Pb (𝑛 = 12) X #
As (𝑛 = 12) X
Mn (𝑛 = 12) X X
Hg (𝑛 = 12)
Groups that displayed behaviors significantly different from expected out-
come are marked with X.
# indicates that significant numbers of test animals had an unscored match.
(𝑝 < 0.005) enriched biological process. The genes in this
group (Rab3gap1, Ptprz1, Col2a1, Chd7, and Nf2) also popu-
lated subsets specific to face development (GO:0060324) and
camera-type eye development (GO:0043010). The synapse
(GO:0045202) was the most significantly (𝑝 < 0.005)
enriched cellular component in VPA treated animals. Col-
lectively, altered facial and neurological development and
dysregulated cellular signaling were indicated. The most
significantly enrichedGOgroupswithMn exposure included
cellular biosynthetic process (𝑝 < 0.01) under the biological
process grouping (GO:0044249), transferase (GO:0016740)
activity under molecular function (𝑝 < 0.01), and intra-
cellular membrane-bounded organelle (GO:0043231) under
cellular component (𝑝 < 0.05).These data are consistent with
an overall impact on biosynthesis, with specific interaction
of calmodulin and transferase activity. In animals exposed to
lead in utero, the organelle (GO:0043226) cellular component
group (𝑝 < 0.05) and protein kinase inhibitor activity
(GO:0004860) molecular function group (𝑝 < 0.001) were
the most significantly enriched.
Enrichment analysis was also conducted for animal phe-
notypes. Specifically, these gene groups produce a common
phenotype when knocked out or mutated. The most sig-
nificantly enriched gene groups by phenotypes were abnor-
mal CNS glial cell morphology (Ptprz1, Pi4k2a, and App;
MP:0000952) and head bobbing (Col2a1, Chd7; MP:0001410)
for VPA treatment (𝑝 < 0.05), decreased body weight
(Ovol1, Trib2, Slc13a5, Lrp5, Hk2, Pi4k2a, Chd7, and Tmeff2;
MP:0001262) for Mn (𝑝 < 0.05), and impaired right-
ing response (Trib2, Dst, Chd7, and Bsn; MP:0001523) for
Pb (𝑝 < 0.001). Pb had an additional twelve signif-
icantly enriched phenotype groups that included prema-
ture death (MP:0002083), abnormal involuntary movement
(MP:0003492), gliosis (MP:0002183), and abnormal cochlear
nerve compound action potential (MP:0004415).
3.2.3. Real-Time Q-PCR Validation. Chd7 was overexpressed
in all three (Mn, Pb, and VPA) treatment groups, as predicted
by microarray data for altered histone methylation. When
compared to water control group the expression of Chd7
was 2.4-, 4.7-, and 1.6-fold higher in Mn, Pb, and VPA
treated groups, respectively. While loss of function has been
demonstrated to be responsible for CHARGE syndrome, in
which affected children may have learning disabilities and
craniofacial malformations, it is unknown at this time what
effects overexpression due to hypomethylation might confer.
4. Discussion
C57 male mice were exposed in utero from the onset of ges-
tation and during neural tube closure to toxicants suspected
of affecting neurodevelopment in humans: VPA (the positive
control treatment), lead, arsenic, cadmium, manganese, and
mercury. Abnormal behavior was observed, compared to
water-treated controls, in several treatment groups: VPA;
manganese and lead.The observed impacts of VPA treatment
were consistent with those found in the literature [34, 49,
50]. These data also indicate that prenatal manganese and
lead exposures are associated with adverse neurobehavioral
development in the resultant offspring.
In recent years, growing evidence suggests that both
genetic and environmental factors contribute to ASDs.There
are indications that certain gene variants confer genetic
susceptibility [51]. Additionally, de novo mutations and
advanced parental age have also been identified as genetically
related risk factors [52, 53]. The observed pathophysiology
of ASD in the central nervous system, including oxidative
stress, neuroinflammation, and mitochondrial dysfunction,
is consistent with environmental exposures to air pollution,
organophosphates, and heavy metals [54].
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Table 3: Differentially methylated regions and associated genes.
VPA Manganese Lead
Gene ID CpG VPA : Ctl Gene ID CpG Mn : Ctl Gene ID CpG Pb : Ctl
Col2a1 chr15 −1.25942 Atf1 chr15 −2.40606 Lpo chr11 −2.1686
Glt25d2 chr1 −1.21282 Lrp5 chr19 −1.53512 Alox5 chr6 −1.94012
App chr16 −1.15531 Ercc3 chr18 −1.42284 Arhgef10 chr8 −1.61243
Chd7 chr4 −1.11644 Pnpla3 chr15 −1.32399 Pkia chr3 −1.29882
Ptprz1 chr6 −1.0547 Gpr120 chr19 −1.18607 Frmd4b chr6 −1.28576
Nf2 chr11 1.022569 Rasgrf2 chr13 −1.13359 Chd7 chr4 −1.14022
Rab3gap1 chr1 1.059968 Chd7 chr4 −1.06245 Derl2 chr11 1.021783
Nmnat2 chr1 1.134621 Hivep2 chr10 1.032248 Ctsf chr19 1.023935
Eif5a chr11 1.442196 Ctxn1 chr8 1.063293 Bsn chr9 1.028517
Pi4k2a chr19 1.548454 Ovol1 chr19 1.087982 Odz2 chr11 1.066651
R3hdm1 chr1 2.132963 Hk2 chr6 1.132845 Rpp38 chr2 1.205103
Slc13a5 chr11 1.200217 Mtx2 chr2 1.403068
Adcy1 chr11 1.272176 Fads3 chr19 1.511005
Scn5a chr9 1.381722 Plxna1 chr6 1.563187
Hs3st3a1 chr11 1.454418 Zbtb5 chr4 1.564412
Pi4k2a chr19 1.532898 Dguok chr6 1.565438
Dmtf1 chr5 1.597027 Dnm2 chr9 1.584182
Gdap1 chr1 1.676317 Trib2 chr12 1.654498
Csmd1 chr8 1.730636 Prpsap2 chr11 1.692807
Tmeff2 chr1 1.771945 Dst chr1 2.000012
Trib2 chr12 1.790036
Hat1 chr2 1.840714
Prmt8 chr6 1.858983
Mrps28 chr3 1.916268
Tnrc6b chr15 1.969439
CpG array probe names were associated with gene IDs (UCSC Genome Browser). All array data was normalized to the internal sheered standard and control
data was compared to experimental data for differential methylation using log
2
ratios. Reported significant differences were defined by >2-fold change, 𝑡-test
(𝑝 < 0.005). The resulting changes in methylation for exposures were 11 for VPA (5 down, 6 up), 25 for Mn (7 down, 18 up), and 20 for Pb (6 down, 14 up).
It has been reported that exposure to industrial chemicals
during early fetal development can cause brain injury at doses
much lower than that affecting adult brain function [55]. The
research on heavy metal exposure and ASD has largely been
focusing on mercury; however, association between an ASD
diagnosis and other toxins including lead andmanganese has
been observed in epidemiology studies [56, 57].
The knowledge on acute neurotoxic effect of lead can be
traced back to the Roman times [58]. During the 1970s, wide
spread subclinical neurobehavioral deficits such as problems
with concentration, memory, and cognition were observed
among children with raised blood lead levels [59–64]. More
recent studies suggest that even low lead exposure could
have greater than previously expected adverse effects on
human brain development [65]. Exposure to low doses of
manganese in children who are particularly susceptible may
lead to subclinical neurotoxicity [55]. Recent studies have
reported that manganese levels and psychomotor and mental
development in children are significantly associated and the
relationship presents as an invertedU-shape [66–68]. Despite
the profoundknowledge regarding neurotoxicity of industrial
chemicals, the relationship between prenatal exposure to low
doses of neurotoxic metals and neurodevelopment in the
offspring remains unclear.
One recent epidemiology study [69] in a Chinese pop-
ulation revealed that high levels of manganese and lead
in umbilical cord blood are associated with neurodevel-
opmental deficit at two years of age. Further, there may
be an interactive effect between manganese and lead that
aggravate this outcome. We used rodent models to carefully
evaluate the spectrum of neurodevelopmental effects caused
by common heavy metals. Our results are consistent with
Lin and coworkers observation in humans and provided
supporting evidence to fill the data gap on in utero exposure
to selected neurotoxins.
When frontal cortex tissue from representative animals
from treatment groups and water-treated controls was eval-
uated for changes in CpG island methylation, data clustering
indicated that changes in methylation showed clear patterns:
clusters fit expected groups based on treatment type. Further,
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one region was found with lower regulation in all treatment
groups. This region is 5󸀠 of the chromodomain-helicase-
DNA-binding protein 7 (Chd7) gene. Real-time qPCR con-
firmed that Chd7 was overexpressed by several fold changes
in all three treatment groups, as predicted bymicroarray data.
While loss of function of this gene has been demonstrated
to be responsible for CHARGE syndrome, in which affected
children often have learning disabilities and craniofacial
malformations, it is unknown at this time what effects
overexpression due to hypomethylation might confer.
In this study, in utero exposure to several toxicants
early in development resulted in behavioral abnormalities
and changes in methylation of CpG islands and associated
changes in expression that were evident in adulthood. The
strength of the study is the combination of four behavioral
assays, as well as molecular assays on gene expression and
methylation status of genes responsive to exposure of toxi-
cants. Investigation of the role ofChd7 and other genes whose
altered methylation state is associated with disrupted social
behavior is warranted. Further, epidemiology studies sug-
gested potential convergent interactions among neurotoxins
and this hypothesis should be examined in rodent models as
described in this study.
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